Can detection and prediction models for Alzheimer's Disease be applied to Prodromal Parkinson's Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures
- PMID: 37645162
- PMCID: PMC10445877
- DOI: 10.12688/openreseurope.14216.2
Can detection and prediction models for Alzheimer's Disease be applied to Prodromal Parkinson's Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures
Abstract
Parkinson's disease (PD) is the fastest growing neurodegeneration and has a prediagnostic phase with a lot of challenges to identify clinical and laboratory biomarkers for those in the earliest stages or those 'at risk'. Despite the current research effort, further progress in this field hinges on the more effective application of digital biomarker and artificial intelligence applications at the prediagnostic stages of PD. It is of the highest importance to stratify such prediagnostic subjects that seem to have the most neuroprotective benefit from drugs. However, current initiatives to identify individuals at risk or in the earliest stages that might be candidates for future clinical trials are still challenging due to the limited accuracy and explainability of existing prediagnostic detection and progression prediction solutions. In this brief paper, we report on a novel digital neuro signature (DNS) for prodromal-PD based on selected digital biomarkers previously discovered on preclinical Alzheimer's disease. (AD). Our preliminary results demonstrated a standard DNS signature for both preclinical AD and prodromal PD, containing a ranked selection of features. This novel DNS signature was rapidly repurposed out of 793 digital biomarker features and selected the top 20 digital biomarkers that are predictive and could detect both the biological signature of preclinical AD and the biological mechanism of a-synucleinopathy in prodromal PD. The resulting model can provide physicians with a pool of patients potentially eligible for therapy and comes along with information about the importance of the digital biomarkers that are predictive, based on SHapley Additive exPlanations (SHAP). Similar initiatives could clarify the stage before and around diagnosis, enabling the field to push into unchartered territory at the earliest stages of the disease.
Keywords: digital neuro signatures; prediagnostic Parkinson's disease; prodromal Parkinson's disease.
Copyright: © 2022 Tarnanas I et al.
Conflict of interest statement
Competing interests: Dr. Ioannis Tarnanas is receiving reimbursements, fees, funding, or salary from Altoida Inc., that holds or has applied for patents relating to the content of the manuscript.
Figures




Similar articles
-
Making pre-screening for Alzheimer's disease (AD) and Postoperative delirium among post-acute COVID-19 syndrome - (PACS) a national priority: The Deep Neuro Study.Open Res Eur. 2022 Aug 22;2:98. doi: 10.12688/openreseurope.15005.1. eCollection 2022. Open Res Eur. 2022. PMID: 37767224 Free PMC article.
-
The prediagnostic phase of Parkinson's disease.J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):871-8. doi: 10.1136/jnnp-2015-311890. Epub 2016 Jan 11. J Neurol Neurosurg Psychiatry. 2016. PMID: 26848171 Free PMC article. Review.
-
Making Pre-screening for Alzheimer's Disease (AD) and Postoperative Delirium Among Post-Acute COVID-19 Syndrome (PACS) a National Priority: The Deep Neuro Study.Adv Exp Med Biol. 2023;1424:41-47. doi: 10.1007/978-3-031-31982-2_4. Adv Exp Med Biol. 2023. PMID: 37486477
-
Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease.Front Neurol. 2021 Aug 6;12:694329. doi: 10.3389/fneur.2021.694329. eCollection 2021. Front Neurol. 2021. PMID: 34421799 Free PMC article. Review.
-
The Concept of Prodromal Parkinson's Disease.J Parkinsons Dis. 2015;5(4):681-97. doi: 10.3233/JPD-150685. J Parkinsons Dis. 2015. PMID: 26485429 Free PMC article. Review.
Cited by
-
Editorial: Advancements of deep learning in medical imaging for neurodegenerative diseases.Front Neurosci. 2024 Jan 19;18:1361055. doi: 10.3389/fnins.2024.1361055. eCollection 2024. Front Neurosci. 2024. PMID: 38312932 Free PMC article. No abstract available.
References
-
- de Rijk MC, Tzourio C, Breteler MM, et al. : Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10–5. 10.1136/jnnp.62.1.10 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources